Literature DB >> 15286178

Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane.

Martha Triantafilou1, Siegfried Morath, Alan Mackie, Thomas Hartung, Kathy Triantafilou.   

Abstract

The innate immune system utilises pattern recognition receptors in order to recognise microbial conserved molecular patterns. The family of Toll-like receptors (TLRs) has been shown to act as the main pattern recognition receptors for the innate immune system. Using biochemical as well as fluorescence imaging techniques, TLR2 and TLR4 were found to be recruited within microdomains upon stimulation by bacterial products. Furthermore their lateral diffusion in the cell membrane as determined by fluorescence recovery after photobleaching revealed that upon stimulation by bacterial products TLRs encounter barriers to their lateral movement, thus supporting the notion that specialised domains on the plasma membrane facilitate the innate recognition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286178     DOI: 10.1242/jcs.01270

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  52 in total

1.  Activation of myeloid cell-specific adhesion class G protein-coupled receptor EMR2 via ligation-induced translocation and interaction of receptor subunits in lipid raft microdomains.

Authors:  Yi-Shu Huang; Nien-Yi Chiang; Ching-Hsun Hu; Cheng-Chih Hsiao; Kai-Fong Cheng; Wen-Pin Tsai; Simon Yona; Martin Stacey; Siamon Gordon; Gin-Wen Chang; Hsi-Hsien Lin
Journal:  Mol Cell Biol       Date:  2012-02-06       Impact factor: 4.272

Review 2.  Endocytosis in plant-microbe interactions.

Authors:  Nathalie Leborgne-Castel; Thibaud Adam; Karim Bouhidel
Journal:  Protoplasma       Date:  2010-09-03       Impact factor: 3.356

Review 3.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

4.  Expression of GM1, a marker of lipid rafts, defines two subsets of human monocytes with differential endocytic capacity and lipopolysaccharide responsiveness.

Authors:  M Maximina Bertha Moreno-Altamirano; Israel Aguilar-Carmona; F Javier Sánchez-García
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

Review 5.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

6.  Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity.

Authors:  Harald Husebye; Øyvind Halaas; Harald Stenmark; Gro Tunheim; Øystein Sandanger; Bjarne Bogen; Andreas Brech; Eicke Latz; Terje Espevik
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

7.  An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.

Authors:  Precious G Motshwene; Martin C Moncrieffe; J Günter Grossmann; Cheng Kao; Murali Ayaluru; Alan M Sandercock; Carol V Robinson; Eicke Latz; Nicholas J Gay
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

Review 8.  Innate immune pattern recognition: a cell biological perspective.

Authors:  Sky W Brubaker; Kevin S Bonham; Ivan Zanoni; Jonathan C Kagan
Journal:  Annu Rev Immunol       Date:  2015-01-02       Impact factor: 28.527

9.  Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.

Authors:  Ryan G Snodgrass; Shurong Huang; Il-Whan Choi; John C Rutledge; Daniel H Hwang
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

10.  Moderate strength (0.23-0.28 T) static magnetic fields (SMF) modulate signaling and differentiation in human embryonic cells.

Authors:  Zhiyun Wang; Anshu Sarje; Pao-Lin Che; Kevin J Yarema
Journal:  BMC Genomics       Date:  2009-08-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.